Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel HGF receptor tyrosine kinase inhibitors described by Kirin Brewery

Feb. 24, 2003

New distribution agreements for Foscan in East Europe and Mediterranean

Feb. 21, 2003

Atypical retinoid exerts potent antiproliferative and proapoptotic effects

Feb. 20, 2003

New preclinical data reported for HuMax-EGFr

Feb. 20, 2003

Eligard 30 mg receives FDA approval

Feb. 20, 2003

PhotoCure submits NDA for Metvix to FDA

Feb. 20, 2003

Purine-based CDK inhibitors newly identified at Cyclacel

Feb. 20, 2003

Further milestone payment made under D-63153 development agreement

Feb. 19, 2003

Animal toxicology program completed for systemic Reolysin

Feb. 19, 2003

Atugen identifies novel cancer target

Feb. 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...